Advanced Medical Solutions Grp PLC
5 July 2000
ADVANCED MEDICAL SOLUTIONS SIGNS DISTRIBUTION AGREEMENT
FOR SWITZERLAND WITH NOVARTIS CONSUMER HEALTH
Winsford, 5 July 2000: Advanced Medical Solutions Group plc ('AMS'), today
announced that it has signed an agreement with Novartis Consumer Health,
Europe, for the distribution of its ActivHealT range of innovative wound
dressings into Switzerland.
This is the third such agreement with Novartis Consumer Health within the last
eight months. An agreement covering UK and Ireland was announced in November
1999 and a second agreement for Germany was finalised in April. AMS now has
strong distribution channels in the majority of the key world-wide consumer
healthcare markets.
Novartis Consumer Health will begin distribution of the advanced woundcare
products under the MerfenR Actiplast brand in late summer 2000.
Commenting on the agreement, Don Evans, Chief Executive of Advanced Medical
Solutions, said:
'We are progressing well with our strategy to increase the global market
presence of our innovative Consumer Advanced Woundcare products. We are
confident that our association with major corporate partners will result in
further expansion into additional global markets later this year.'
Michel Orsinger, Regional Director of Europe, Novartis Consumer Health, added:
'Following the successful launch in February, Savlon ActivHealT now has
distribution in Boots, Tesco and the majority of independent pharmacies. With
the recent launch in Germany and impending launch in Switzerland, we are
confident of repeating the success in these key strategic markets.'
Advanced Medical Solutions is a leading global company in the development and
manufacture of products for the advanced wound-care market. This is currently
estimated to be in excess of US$1 billion world-wide (1999).
Novartis is a world leader in healthcare with core businesses in
pharmaceuticals, consumer health, generics, eye-care, and animal health and
operates in over 140 countries around the world. The Consumer Health
business, headquartered in Nyon, Switzerland, manufactures, develops and
markets a wide range of branded products, the purpose of which is to restore,
maintain or improve consumer health.
Enquiries:
Advanced Medical Solutions Group plc
Don Evans, Chief Executive Officer Tel: 01606 863500
Mary Tavener, Group Finance Director
www.admedsol.com
Gavin Anderson & Co
Philip Ward / Charlotte Stone Tel: 0207 457 2345
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.